2716 related articles for article (PubMed ID: 23890935)
21. Factors affecting the quality of life of patients with idiopathic Parkinson's disease--a cross-sectional study in an outpatient clinic attendees.
Sławek J; Derejko M; Lass P
Parkinsonism Relat Disord; 2005 Nov; 11(7):465-8. PubMed ID: 16154794
[TBL] [Abstract][Full Text] [Related]
22. The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease.
Martinez-Martin P; Rodriguez-Blazquez C; Kurtis MM; Chaudhuri KR;
Mov Disord; 2011 Feb; 26(3):399-406. PubMed ID: 21264941
[TBL] [Abstract][Full Text] [Related]
23. [The impact of levodopa-carbidopa intestinal gel on health-related quality of life in Parkinson's disease].
Kovács N; Aschermann Z; Ács P; Bosnyák E; Deli G; Janszky J; Komoly S
Ideggyogy Sz; 2014 Jul; 67(7-8):245-50. PubMed ID: 25509365
[TBL] [Abstract][Full Text] [Related]
24. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
Weintraub D; Moberg PJ; Duda JE; Katz IR; Stern MB
J Am Geriatr Soc; 2004 May; 52(5):784-8. PubMed ID: 15086662
[TBL] [Abstract][Full Text] [Related]
25. Importance of motor vs. non-motor symptoms for health-related quality of life in early Parkinson's disease.
Müller B; Assmus J; Herlofson K; Larsen JP; Tysnes OB
Parkinsonism Relat Disord; 2013 Nov; 19(11):1027-32. PubMed ID: 23916654
[TBL] [Abstract][Full Text] [Related]
26. Effect of impulse control disorders on disability and quality of life in Parkinson's disease patients.
Phu AL; Xu Z; Brakoulias V; Mahant N; Fung VS; Moore GD; Martin A; Starcevic V; Krause M
J Clin Neurosci; 2014 Jan; 21(1):63-6. PubMed ID: 24035421
[TBL] [Abstract][Full Text] [Related]
27. Long-term impact on quality of life of subthalamic nucleus stimulation in Parkinson's disease.
Lezcano E; Gómez-Esteban JC; Tijero B; Bilbao G; Lambarri I; Rodriguez O; Villoria R; Dolado A; Berganzo K; Molano A; de Gopegui ER; Pomposo I; Gabilondo I; Zarranz JJ
J Neurol; 2016 May; 263(5):895-905. PubMed ID: 26964542
[TBL] [Abstract][Full Text] [Related]
28. Gender and onset age-related features of non-motor symptoms of patients with Parkinson's disease--a study from Southwest China.
Guo X; Song W; Chen K; Chen X; Zheng Z; Cao B; Huang R; Zhao B; Wu Y; Shang HF
Parkinsonism Relat Disord; 2013 Nov; 19(11):961-5. PubMed ID: 23849500
[TBL] [Abstract][Full Text] [Related]
29. Bladder symptoms assessed with overactive bladder questionnaire in Parkinson's disease.
Iacovelli E; Gilio F; Meco G; Fattapposta F; Vanacore N; Brusa L; Giacomelli E; Gabriele M; Rubino A; Locuratolo N; Iani C; Pichiorri F; Colosimo C; Carbone A; Palleschi G; Inghilleri M
Mov Disord; 2010 Jul; 25(9):1203-9. PubMed ID: 20310046
[TBL] [Abstract][Full Text] [Related]
30. [Effects of non-motor symptoms on health-related quality of life in Parkinson's disease].
Dong H; Liu C; Hu X
Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(11):813-5. PubMed ID: 24854746
[TBL] [Abstract][Full Text] [Related]
31. Impact of pre-morbid depression on health-related quality of life in non-demented Parkinson's disease patients.
Klepac N; Hajnsek S; Trkulja V
Parkinsonism Relat Disord; 2010 Jan; 16(1):21-7. PubMed ID: 19640772
[TBL] [Abstract][Full Text] [Related]
32. Validation of the Italian version of the Non Motor Symptoms Scale for Parkinson's disease.
Cova I; Di Battista ME; Vanacore N; Papi CP; Alampi G; Rubino A; Valente M; Meco G; Contri P; Di Pucchio A; Lacorte E; Priori A; Mariani C; Pomati S
Parkinsonism Relat Disord; 2017 Jan; 34():38-42. PubMed ID: 28029554
[TBL] [Abstract][Full Text] [Related]
33. Beneficial effects of bilateral subthalamic stimulation on alexithymia in Parkinson's disease.
Dafsari HS; Ray-Chaudhuri K; Mahlstedt P; Sachse L; Steffen JK; Petry-Schmelzer JN; Dembek TA; Reker P; Barbe MT; Visser-Vandewalle V; Fink GR; Timmermann L
Eur J Neurol; 2019 Feb; 26(2):222-e17. PubMed ID: 30107062
[TBL] [Abstract][Full Text] [Related]
34. [Neuropsychiatric problems in patients with Parkinson's disease].
Zhou MZ; Liu ZG; Gan J; Chen W; Lu LX; Wu JY
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(21):1442-5. PubMed ID: 18953846
[TBL] [Abstract][Full Text] [Related]
35. The clinically important difference on the unified Parkinson's disease rating scale.
Shulman LM; Gruber-Baldini AL; Anderson KE; Fishman PS; Reich SG; Weiner WJ
Arch Neurol; 2010 Jan; 67(1):64-70. PubMed ID: 20065131
[TBL] [Abstract][Full Text] [Related]
36. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
Jost WH; Klasser M; Reichmann H
Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
[TBL] [Abstract][Full Text] [Related]
37. Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale.
Martinez-Martin P; Chaudhuri KR; Rojo-Abuin JM; Rodriguez-Blazquez C; Alvarez-Sanchez M; Arakaki T; Bergareche-Yarza A; Chade A; Garretto N; Gershanik O; Kurtis MM; Martinez-Castrillo JC; Mendoza-Rodriguez A; Moore HP; Rodriguez-Violante M; Singer C; Tilley BC; Huang J; Stebbins GT; Goetz CG
Eur J Neurol; 2015 Jan; 22(1):37-43. PubMed ID: 23607783
[TBL] [Abstract][Full Text] [Related]
38. Small intestinal bacterial overgrowth in Parkinson's disease.
Tan AH; Mahadeva S; Thalha AM; Gibson PR; Kiew CK; Yeat CM; Ng SW; Ang SP; Chow SK; Tan CT; Yong HS; Marras C; Fox SH; Lim SY
Parkinsonism Relat Disord; 2014 May; 20(5):535-40. PubMed ID: 24637123
[TBL] [Abstract][Full Text] [Related]
39. Independent validation of the non motor symptoms scale for Parkinson's disease in Brazilian patients.
Carod-Artal FJ; Martinez-Martin P
Parkinsonism Relat Disord; 2013 Jan; 19(1):115-9. PubMed ID: 22981311
[TBL] [Abstract][Full Text] [Related]
40. [Health-related quality of life in Parkinson's disease].
Cano-de la Cuerda R; Vela-Desojo L; Miangolarra-Page JC; Macías-Macías Y; Muñoz-Hellin E
Medicina (B Aires); 2010; 70(6):503-7. PubMed ID: 21163736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
